References
- Akman MA, Erden HF, Tosun SB, et al. Comparison of agonistic flare-up-protocol and antagonistic multiple dose protocol in ovarian stimulation of poor responders: results of a prospective randomized trial. Hum Reprod 2001;16:868–70
- Surrey ES, Schoolcraft WB. Evaluating the strategies for improving ovarian response of the poor responders undergoing assisted reproduction techniques. Fertil Steril 2000;73:667–76
- Ferraretti AP, La Marca A, Fauser BC, et al. ESHRE working group on Poor Ovarian Response Definition. ESHRE consensus on the definition of ‘poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod 2011;26:1616–24
- Kucuk T, Kozinoglu H, Kaba A. Growth hormone co-treatement with a GnRH agonist long protocol in patients with poor ovarian response: a prospective randomized clinical trial. J Assist Reprod Genetics 2008;25:123–7
- Bachelot A, Monget P, Imbert-Bollore P, et al. Growth hormone is required for ovarian follicular growth. Endocrinology 2002;143:4104–12
- Kyrou D, Kolibianakis EM, Venetis CA, et al. How to improve the probability of pregnancy in poor responders undergoing in-vitro fertilization: a systematic review and meta-analysis. Fertil Steril 2009;91:749–66
- Madani T, Ashrafi M, Yeganeh LM. Comparison of different stimulation protocols efficacy in poor responders undergoing IVF: a retrospective study. Gynecol Endocrinol 2012;28:102–5
- Karimzadeh MA, Mashayekhy M, Mohammadian F, Moghaddam FM. Comparison of mild and micro dose GnRH agonist flare protocols on IVF outcome in poor responders. Arch Gynecol Obstet 2011;283:1159–64
- Fasouliotis SJ, Laufer N, Sabbagh-Ehrlich S, et al. Gonadotropin-releasing hormone (GnRH)-antagonist versus GnRH-agonist in ovarian stimulation of poor responders undergoing IVF. J Assist Reprod Genet 2003;20:455–60
- Cheung LP, Lam PM, Lok IH, et al. GnRH antagonist versus long GnRH agonist protocol in poor responders undergoing IVF: a randomized controlled trial. Hum Reprod 2005;20:616–21
- Griesinger G, Diedrich K, Tarlatzis BC, Kolibianakis EM. GnRH-antagonists in ovarian stimulation for IVF in patients with poor response to gonadotrophins, polycystic ovary syndrome, and risk of ovarian hyperstimulation: a meta analysis. Reprod Biomed Online 2006;13:628–38
- Leung PCK. GnRH receptor and potential action in human ovary. Gynecol Endocrinol 1999;13:10–17
- Olivennes F, Alvarez S, Bouchard P, et al. The use of GnRH-antagonist (cetrorelix) in a single dose protocol in IVF-embryo transfer: a dose finding study of 3 versus 2 mg. Hum Reprod 1998;13:2411–14
- Fasouliotis SJ, Simon A, Laufer N. Evaluation and treatment of low responders in assisted reproductive technology: a challenge to meet. J Assist Reprod Genet 2000;17:357–73
- Nikolettos N, Al-Hasani S, Felberbaum R, et al. Gonadotropin-releasing hormone antagonist protocol: a novel method of ovarian stimulation in poor responders. Eur J Obstet Gynecol Reprod Biol 2001;97:202–7
- Faber BM, Mayer J, Cox B, et al. Cessation of gonadotropin-releasing hormone agonist therapy combined with high-dose gonadotropin stimulation yields favorable pregnancy results in low responders. Fertil Steril 1998;69:826–30
- Scott RT, Navot D. Enhancement of ovarian responsiveness with microdoses of gonadotropin-releasing hormone agonist during ovulation induction for in vitro fertilization. Fertil Steril 1994;61:880–5